Literature DB >> 11786644

Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Susanne J Szabo1, Brandon M Sullivan, Claudia Stemmann, Abhay R Satoskar, Barry P Sleckman, Laurie H Glimcher.   

Abstract

T-bet is a member of the T-box family of transcription factors that appears to regulate lineage commitment in CD4 T helper (TH) lymphocytes in part by activating the hallmark TH1 cytokine, interferon-gamma (IFN-gamma). IFN-gamma is also produced by natural killer (NK) cells and most prominently by CD8 cytotoxic T cells, and is vital for the control of microbial pathogens. Although T-bet is expressed in all these cell types, it is required for control of IFN-gamma production in CD4 and NK cells, but not in CD8 cells. This difference is also apparent in the function of these cell subsets. Thus, the regulation of a single cytokine, IFN-gamma, is controlled by distinct transcriptional mechanisms within the T cell lineage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786644     DOI: 10.1126/science.1065543

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  442 in total

1.  T-bet regulates IgG class switching and pathogenic autoantibody production.

Authors:  Stanford L Peng; Susanne J Szabo; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation.

Authors:  Kirsten M L Hertoghs; Perry D Moerland; Amber van Stijn; Ester B M Remmerswaal; Sila L Yong; Pablo J E J van de Berg; S Marieke van Ham; Frank Baas; Ineke J M ten Berge; René A W van Lier
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 3.  An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation.

Authors:  Ryoji Yagi; Jinfang Zhu; William E Paul
Journal:  Int Immunol       Date:  2011-06-01       Impact factor: 4.823

4.  Increased numbers of preexisting memory CD8 T cells and decreased T-bet expression can restrain terminal differentiation of secondary effector and memory CD8 T cells.

Authors:  Nikhil S Joshi; Weiguo Cui; Claudia X Dominguez; Jonathan H Chen; Timothy W Hand; Susan M Kaech
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

Review 5.  Helper T cell differentiation and the problem of cellular inheritance.

Authors:  Steven L Reiner; Alan C Mullen; Anne S Hutchins; Erika L Pearce
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

6.  c-Rel delivers a one-two punch in Th1 cell differentiation.

Authors:  Sung-Yun Pai; I-Cheng Ho
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  T-bet and mucosal Th1 responses in the gastrointestinal tract.

Authors:  B Weigmann; M F Neurath
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

8.  MHTP, 2-Methoxy-4-(7-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl) phenol, a Synthetic Alkaloid, Induces IFN-γ Production in Murine Model of Ovalbumin-Induced Pulmonary Allergic Inflammation.

Authors:  Laércia K D Paiva Ferreira; Larissa A M Paiva Ferreira; Adriano Francisco Alves; Fagner Carvalho Leite; Luiz A de Araújo Silva; Giciane Carvalho Vieira; Luís Cezar Rodrigues; Marcia Regina Piuvezam
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

9.  Naive CD4+ T Cells Carrying a TLR2 Agonist Overcome TGF-β-Mediated Tumor Immune Evasion.

Authors:  Mohsen Ibrahim; Davide Scozzi; Kelsey A Toth; Donatella Ponti; Daniel Kreisel; Cecilia Menna; Elena De Falco; Antonio D'Andrilli; Erino A Rendina; Antonella Calogero; Alexander S Krupnick; Andrew E Gelman
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

10.  CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy.

Authors:  Hong Chen; Tihui Fu; Woong-Kyung Suh; Dimitra Tsavachidou; Sijin Wen; Jianjun Gao; Derek Ng Tang; Qiuming He; Jingjing Sun; Padmanee Sharma
Journal:  Cancer Immunol Res       Date:  2013-11-19       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.